Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Impact on patients' health status following early identification of a COPD exacerbation.

Impact on patients' health status following early identification of a COPD exacerbation. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Impact on patients' health status following early identification of a COPD exacerbation. Abstract Text:

    j bourbeauJ Bourbeau,g fordG Ford,h zackonH Zackon,n pinskyN Pinsky,j leeJ Lee,g rubertoG Ruberto,j bourbeauJ Bourbeau,g fordG Ford,h zackonH Zackon,n pinskyN Pinsky,j leeJ Lee,g rubertoG Ruberto,

    The current study aimed to assess the impact on patient health status during an acute exacerbation of chronic obstructive pulmonary disease (AECOPD). A total of 421 COPD patients were enrolled in a multicentre, single-arm study with a 6-month observational follow-up period. Patients received two inhalations of Symbicort 200 Turbuhaler(R) twice a day. Patients were assessed before the run-in period, at baseline and at 1, 3 and 6 months. Patients were instructed to report a change in respiratory symptoms lasting >24 h. This defined an AECOPD. In addition to the initial call, the St George's Respiratory Questionnaire (SGRQ), COPD Control Questionnaire (CCQ), Medical Research Council (MRC) dyspnoea scale and activities of daily living (ADL) were completed at 5-7 and 12-14 days. A group of 176 patients reported at least one AECOPD. Exacerbations were associated with statistically significant mean changes (worsening) in the SGRQ activity and impact domains at onset (mean +/- sd 12.1 +/- 18.1 and 14.0 +/- 15.2), during the first (9.8 +/- 19.0 and 9.4 +/- 16.6) and second weeks (3.1 +/- 15.5 and 3.3 +/- 14.7). Clinically significant deterioration in SGRQ impact scores was shown in 71% of patients following early identification, with 55 and 37% during the first and second weeks of an AECOPD, respectively. Acute exacerbation severely impacts on health status. The current study provides valuable information on the change in health status during an acute exacerbation of chronic obstructive pulmonary disease that can be utilised for future trials that evaluate therapeutic intervention.

    Impact on patients' health status following early identification of a COPD exacerbation. Publishing Authors By Initials

    j bourbeauJ Bourbeau,g fordG Ford,h zackonH Zackon,n pinskyN Pinsky,j leeJ Lee,g rubertoG Ruberto,j bourbeauJ Bourbeau,g fordG Ford,h zackonH Zackon,n pinskyN Pinsky,j leeJ Lee,g rubertoG Ruberto,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Impact on patients' health status following early identification of a COPD exacerbation. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: The European respiratory journal : official journa

    VOLUME: 30

    Page Numbers: 907-13

    Journal Abbreviation: Eur. Respir. J.

    ISSN: 0903-1936

    DAY: 22

    MONTH: 08

    YEAR: 2007

    Impact on patients' health status following early identification of a COPD exacerbation. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8803460

    Impact on patients' health status following early identification of a COPD exacerbation. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Impact on patients' health status following early identification of a COPD exacerbation. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Impact on patients' health status following early identification of a COPD exacerbation.

    AFFILIATION: Respiratory Epidemiology and Clinical Research Unit, Montreal Chest Institute, 3650 St Urbain, Montréal, QC, Canada. jean.bourbeau@mcgill.ca

    Country: Switzerland

    Switzerland Research PublicationSwitzerland Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Eur Respir J

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Impact on patients' health status following early identification of a COPD exacerbation Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News